Entera Bio Statistics
NASDAQ: ENTXHealthcareBiotechnologyUSD
2.51-0.02 (-0.79%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Entera Bio by the numbers
Entera Bio has a market capitalization of $436.3 million based on 173.83M shares outstanding. With trailing EPS of $-0.36, Entera Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.6% below its 50-day average and 38.8% above its 200-day average.
Average daily trading volume is 1.81M shares, or about $4.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ENTX valuation vs. peer median
| Metric | ENTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $436.32M | $433.49M | +1% |
| Avg. volume | 1.81M | 979.45K | +85% |
Peer median across 8 companies: TECX, PRTA, SPRY, AGMB, DMAC, RZLT, EDIT, OVID.
Valuation
- Market cap
- $436.32M
- EPS (TTM)
- $-0.36
- Shares outstanding
- 173.83M
Price and trading
- Previous close
- 2.53
- Open
- 2.51
- Day range
- 2.45 – 2.58
- 52-week range
- 0.91 – 4.20
- 52-week change
- +32.80%
- Beta
- —
- Volume
- 679.46K
- Average volume
- 1.81M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 436.32M
- Forward Pe
- -4.56
- Eps
- -0.36
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.20
- Week52 Low
- 0.91
- Avg Volume
- 1.81M
- Shares Outstanding
- 173.83M
- Ma50
- 2.94
- Ma200
- 1.81
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -40.24%
- Pct From52w Low
- 175.82%